{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:12:48Z","timestamp":1788797568950,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lactate dehydrogenase (LDH) as a hypoxia-regulator plays a vital role in alternative metabolic pathways of cancer cells. Numerous studies have assessed the prognostic value of elevated pretreatment LDH in malignant mesothelioma (MM). However, the results have been largely inconsistent. Hence, the aim of current study was to investigate the prognostic value of pretreatment LDH levels in patients with MM by performing a meta-analysis of relevant studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A literature search for English language studies, which investigated the association of LDH levels with overall survival (OS) in malignant mesothelioma, was performed in the electronic databases, PubMed, Medline, Embase, and Web of Science. Pooled hazard ratios (HRs) and their 95% confidence intervals (95% CIs) were calculated. Heterogeneity was assessed using Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      statistics. Sensitivity analysis, meta-regression model, and subgroup analysis were performed to trace the source of heterogeneity, if applicable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 9 studies with a combined study population of 1977 patients came within the purview of this meta analysis. Pooled HR for OS in patients with high LDH level was 1.68 (95% CI\u200a=\u200a1.36\u20132.00). Significant heterogeneity was observed in the included studies (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a54.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a0.026). Sensitivity analysis after sequential exclusion of 1 study at a time, and meta-regression with inclusion of 6 confounding factors failed to identify the source of heterogeneity. However, in the subgroup analysis, it was found that the publication of Nojiri et al was the origin of heterogeneity. When omitted the publication of Nojiri et al, the pooled HR of the rest 8 studies was 1.83 (95% CI\u200a=\u200a1.45\u20132.20,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u200a=\u200a0.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a0.723). Egger test and funnel plots excluded the possibility of publication bias affecting the results of the current meta-analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A negative association was observed between high LDH levels and poor overall survival in the current study. Our findings suggest that pretreatment LDH level could serve as a useful predictor of prognosis in patients with malignant mesothelioma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000005706","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T14:06:09Z","timestamp":1483020369000},"page":"e5706","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma"],"prefix":"10.1097","volume":"95","author":[{"given":"Yi","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20260907","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"R2-28-20260907","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"Roe","year":"2015","journal-title":"Eur Respir Rev"},{"key":"R3-28-20260907","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002680020021","article-title":"Treatment of malignant mesothelioma","volume":"25","author":"Jaklitsch","year":"2001","journal-title":"World J Surg"},{"key":"R4-28-20260907","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R5-28-20260907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-5002(95)00508-0","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group","volume":"14","author":"Rusch","year":"1996","journal-title":"Lung Cancer"},{"key":"R6-28-20260907","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"R7-28-20260907","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-11-0397","article-title":"Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype","volume":"17","author":"Serganova","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R8-28-20260907","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1440-1843.2011.02070.x","article-title":"Factors associated with long-term survival of patients with advanced non-small cell lung cancer","volume":"17","author":"Giroux Leprieur","year":"2012","journal-title":"Respirology"},{"key":"R9-28-20260907","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.2013.475","article-title":"Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial","volume":"109","author":"Giessen","year":"2013","journal-title":"Br J Cancer"},{"key":"R10-28-20260907","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.2013.52.3696","article-title":"Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer","volume":"32","author":"Halabi","year":"2014","journal-title":"J Clin Oncol"},{"key":"R11-28-20260907","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1097-0142(20010315)91:6<1079::AID-CNCR1103>3.0.CO;2-S","article-title":"Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy","volume":"91","author":"Pierga","year":"2001","journal-title":"Cancer"},{"key":"R12-28-20260907","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/030089160409000507","article-title":"Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years","volume":"90","author":"Bacci","year":"2004","journal-title":"Tumori"},{"key":"R13-28-20260907","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"R14-28-20260907","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/rmed.2001.1178","article-title":"Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics","volume":"95","author":"Metintas","year":"2001","journal-title":"Respir Med"},{"key":"R15-28-20260907","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/JTO.0b013e3181ba2033","article-title":"Prognostic factors according to the treatment schedule in malignant pleural mesothelioma","volume":"4","author":"Ak","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R16-28-20260907","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000321370","article-title":"A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma","volume":"80","author":"Tanrikulu","year":"2010","journal-title":"Respiration"},{"key":"R17-28-20260907","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jjco\/hyq159","article-title":"Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan","volume":"41","author":"Nojiri","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"R18-28-20260907","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2169\/internalmedicine.51.6236","article-title":"Prognostic factors in malignant pleural mesothelioma: a retrospective study","volume":"51","author":"Suzuki","year":"2012","journal-title":"Intern Med"},{"key":"R19-28-20260907","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00408-013-9516-y","article-title":"Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysis","volume":"192","author":"Suzuki","year":"2014","journal-title":"Lung"},{"key":"R20-28-20260907","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0300060513504163","article-title":"The value of inflammatory parameters in the prognosis of malignant mesothelioma","volume":"42","author":"Abakay","year":"2014","journal-title":"J Int Med Res"},{"key":"R21-28-20260907","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jjco\/hyv039","article-title":"A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index","volume":"45","author":"Kataoka","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"R22-28-20260907","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"R23-28-20260907","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R24-28-20260907","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"R25-28-20260907","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R26-28-20260907","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00432-014-1644-0","article-title":"Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis","volume":"140","author":"Chen","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R27-28-20260907","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1038\/srep09800","article-title":"Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"R28-28-20260907","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"R29-28-20260907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumour acidity and implications for treatment","volume":"6","author":"Stubbs","year":"2000","journal-title":"Mol Med Today"},{"key":"R30-28-20260907","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","article-title":"Ketones and lactate \u201cfuel\u201d tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism","volume":"9","author":"Bonuccelli","year":"2010","journal-title":"Cell Cycle"},{"key":"R31-28-20260907","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4161\/cc.10.8.15330","article-title":"Ketones and lactate increase cancer cell \u201cstemness,\u201d driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"key":"R32-28-20260907","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1128\/MCB.20.19.7311-7318.2000","article-title":"Role for mitochondrial oxidants as regulators of cellular metabolism","volume":"20","author":"Nemoto","year":"2000","journal-title":"Mol Cell Biol"},{"key":"R33-28-20260907","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J Biol Chem"},{"key":"R34-28-20260907","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1200\/JCO.2006.05.9501","article-title":"Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway\u2014a report of the Tumour Angiogenesis Research Group","volume":"24","author":"Koukourakis","year":"2006","journal-title":"J Clin Oncol"},{"key":"R35-28-20260907","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1245\/s10434-008-9955-5","article-title":"Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis","volume":"15","author":"Kolev","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R36-28-20260907","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-28-20260907","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/or.2013.2735","article-title":"Inhibition of LDH-A by oxamate induces G2\/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells","volume":"30","author":"Zhai","year":"2013","journal-title":"Oncol Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:04:09Z","timestamp":1788797049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00028"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005706","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}